Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic consequences. [electronic resource]
Producer: 20050630Description: 757-8 p. digitalISSN:- 0149-5992
- Adult
- Aged
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Benzimidazoles -- therapeutic use
- Benzoates -- therapeutic use
- Biphenyl Compounds
- Blood Pressure -- drug effects
- Diabetes Mellitus, Type 2 -- complications
- Diabetic Angiopathies -- drug therapy
- Female
- Humans
- Hypertension -- drug therapy
- Male
- Middle Aged
- Telmisartan
- Tetrazoles -- therapeutic use
- Valine -- analogs & derivatives
- Valsartan
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Letter
There are no comments on this title.
Log in to your account to post a comment.